12 
in the Federal Register together with a statement of the basis for the 
order. 
Relationship to other Federal laws ( section 108) 
Section 108(a) specifies that title I shall not affect the authority of 
any Executive Agency to regulate recombinant DNA activities under 
any other Act. 
Section 108(b) establishes that the Secretary shall not be deemed 
to be exercising statutory authority under section 4(b) (1) of the 
Occupational Safety and Health Act of 1970, in exercising any au- 
thority under title I of this act. 
Title II— Commission for the Study of Research and Technology In- 
voicing Genetic Manipulation 
Section 201 provides for the establishment of a thirteen member 
Commission for the Study of Research and Technology Involving 
Genetic Manipulation. The members of the Commission are to be ap- 
pointed by the Secretary of HEW from individuals distinguished in 
the fields of medicine, law, ethics, the biological, physical, and environ- 
mental sciences, philosophy, humanities, health administration, gov- 
ernment and public affairs. 
Section 202 sets forth the duties of the Commission which include 
(1) the conduct of a study of Federal policy regarding activities in- 
volving the genetic modifications of organisms and viruses, and (2) a 
study of the long-term consequences of the development of a technol- 
ogy capable of accomplishing the genetic modification of organisms 
and viruses. 
Section 203 requires the Commission, in carrying out its duties, to 
hold public hearings as appropriate, and requires the head of any U.S. 
department or agency to furnish to the Commission, upon its request, 
information necessary to enable the Commission to carry out its duties. 
Section 204 requires the Secretary, within 18 months after the date 
of enactment, to report to the Congress the preliminary results of he 
Commission’s study with respect to Federal policy regarding activi- 
ties involving the genetic modification of organisms and viruses. It 
further provides that the Commission, within 30 months after the 
date of enactment, is to complete its studies and make recommenda- 
tions to the Congress, the President, and appropriate Federal agencies 
regarding action the Commission determines should be taken to pro- 
mote, regulate, or review activities involving the genetic modification 
of organisms and viruses. Finally, it provides that the Commission 
shall terminate within 60 days of the date upon which is completed 
its studies and made its recommendations. 
ANALYSIS OF SECTIONS AND COMMITTEE VIEWS 
Section 1. Short title 
The first section of H.R. 11192 as reported by the Committee, pro- 
vides that this legislation may be cited as the “Recombinant DNA 
Act’’. 
Section 2. Findings 
The purpose of these findings is not only to formally recognize that 
recombinant DNA techniques may provide an extremely important 
[Appendix B — 142] 
